A 3D culture platform enables development of zinc-binding prodrugs for targeted proliferation of β cells.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
11 2020
Historique:
received: 23 04 2020
accepted: 07 10 2020
entrez: 19 11 2020
pubmed: 20 11 2020
medline: 15 4 2022
Statut: epublish

Résumé

Advances in treating β cell loss include islet replacement therapies or increasing cell proliferation rate in type 1 and type 2 diabetes, respectively. We propose developing multiple proliferation-inducing prodrugs that target high concentration of zinc ions in β cells. Unfortunately, typical two-dimensional (2D) cell cultures do not mimic in vivo conditions, displaying a markedly lowered zinc content, while 3D culture systems are laborious and expensive. Therefore, we developed the Disque Platform (DP)-a high-fidelity culture system where stem cell-derived β cells are reaggregated into thin, 3D discs within 2D 96-well plates. We validated the DP against standard 2D and 3D cultures and interrogated our zinc-activated prodrugs, which release their cargo upon zinc chelation-so preferentially in β cells. Through developing a reliable screening platform that bridges the advantages of 2D and 3D culture systems, we identified an effective hit that exhibits 2.4-fold increase in β cell proliferation compared to harmine.

Identifiants

pubmed: 33208361
pii: 6/47/eabc3207
doi: 10.1126/sciadv.abc3207
pmc: PMC7673808
pii:
doi:

Substances chimiques

Prodrugs 0
Zinc J41CSQ7QDS

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK113597
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK104165
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK116255
Pays : United States

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

Heliyon. 2016 Jun 28;2(6):e00129
pubmed: 27441299
J Biol Chem. 2015 Aug 28;290(35):21432-42
pubmed: 26178371
J Pharmacol Toxicol Methods. 2016 Nov - Dec;82:83-89
pubmed: 27554916
Cell Metab. 2016 Oct 11;24(4):616-626
pubmed: 27732837
Diabetes. 1986 Apr;35(4):379-86
pubmed: 3514322
Nature. 1994 Oct 6;371(6497):487-92
pubmed: 7935761
Diabetes Obes Metab. 2008 Nov;10 Suppl 4:23-31
pubmed: 18834430
Diabetes. 2000 Feb;49(2):157-62
pubmed: 10868930
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14920-5
pubmed: 14657333
Stem Cells. 2007 Dec;25(12):3155-64
pubmed: 17761759
Nat Biotechnol. 2011 Jul 31;29(8):750-6
pubmed: 21804561
Transplantation. 2009 Apr 15;87(7):983-91
pubmed: 19352116
BMC Cancer. 2018 Jan 5;18(1):36
pubmed: 29304760
Chem Commun (Camb). 2012 Jun 4;48(44):5449-51
pubmed: 22535325
Diabetes. 2005 Jun;54(6):1798-807
pubmed: 15919802
Diabetes Obes Metab. 2017 Sep;19 Suppl 1:124-136
pubmed: 28880471
J Proteome Res. 2013 Dec 6;12(12):5954-62
pubmed: 24006944
J Am Chem Soc. 2009 Dec 30;131(51):18327-34
pubmed: 19950931
Int J Mol Sci. 2016 Dec 13;17(12):
pubmed: 27983594
Science. 2001 May 18;292(5520):1389-94
pubmed: 11326082
Diabetes. 2001 Mar;50(3):521-33
pubmed: 11246871
Cell. 2014 Oct 9;159(2):428-39
pubmed: 25303535
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):143-8
pubmed: 24335702
Inorg Chem. 2009 Dec 7;48(23):11297-309
pubmed: 19886646
Curr Diabetes Rev. 2010 Jan;6(1):52-7
pubmed: 20034370
PLoS One. 2015 Jul 20;10(7):e0132453
pubmed: 26192590
Nat Protoc. 2009;4(3):309-24
pubmed: 19214182
Nature. 1995 Aug 10;376(6540):520-1
pubmed: 7637784
Exp Toxicol Pathol. 2008 Aug;60(4-5):381-9
pubmed: 18430551
J Diabetes Investig. 2012 Jun 6;3(3):202-11
pubmed: 24843567
Nanoscale. 2017 Dec 7;9(47):18737-18752
pubmed: 29168523
Cell Transplant. 2009;18(1):1-12
pubmed: 19476204
Diabetes. 2005 Jul;54(7):2060-9
pubmed: 15983207
Endocrine. 2015 Sep;50(1):110-22
pubmed: 25771886
Tissue Eng Part A. 2013 Mar;19(5-6):604-12
pubmed: 23004004
Cell Res. 2009 Apr;19(4):429-38
pubmed: 19255591
Curr Opin Endocrinol Diabetes Obes. 2013 Feb;20(1):1-7
pubmed: 23249759
J Am Chem Soc. 2020 Apr 8;142(14):6477-6482
pubmed: 32175731
Cell Tissue Res. 2012 Mar;347(3):701-11
pubmed: 21833761
J Med Chem. 2018 Sep 13;61(17):7687-7699
pubmed: 30059217
Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1865-70
pubmed: 17267606
Biomaterials. 2013 Sep;34(28):6607-14
pubmed: 23777909
Diabetes Obes Metab. 2016 Sep;18 Suppl 1:71-7
pubmed: 27615134
Diabetologia. 2013 Jul;56(7):1557-68
pubmed: 23604550
Cancer Biother. 1993 Summer;8(2):145-58
pubmed: 7528598
PLoS One. 2013 Aug 15;8(8):e72612
pubmed: 23977329
Diabetologia. 2012 May;55(5):1346-54
pubmed: 22286529
Nature. 2019 May;569(7756):368-373
pubmed: 31068696
Cytometry A. 2013 Dec;83(12):1096-104
pubmed: 24136923
Endocrine. 2014 Mar;45(2):178-89
pubmed: 23979673
Sci Rep. 2016 Sep 14;6:33204
pubmed: 27625151
Biofabrication. 2019 Jun 04;11(3):035024
pubmed: 31051482
J Cell Sci. 2006 Oct 15;119(Pt 20):4199-206
pubmed: 16984975
Nat Med. 2015 Apr;21(4):383-8
pubmed: 25751815
PLoS One. 2012;7(4):e34303
pubmed: 22558087
J Physiol. 2011 Nov 15;589(Pt 22):5453-66
pubmed: 21930600
J Mater Chem B. 2019 Mar 14;7(10):1773-1781
pubmed: 32254919
Exp Cell Res. 2004 Apr 1;294(2):379-91
pubmed: 15023528
Adv Healthc Mater. 2015 Mar 11;4(4):511-5
pubmed: 25323327

Auteurs

Kisuk Yang (K)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.
Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02142, USA.

Miseon Lee (M)

Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

Peter Anthony Jones (PA)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.

Sophie S Liu (SS)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Angela Zhou (A)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Jun Xu (J)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Vedagopuram Sreekanth (V)

Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

Jamie L Y Wu (JLY)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Lillian Vo (L)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Eunjee A Lee (EA)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.

Ramona Pop (R)

Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.

Yuhan Lee (Y)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.

Bridget K Wagner (BK)

Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Douglas A Melton (DA)

Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.

Amit Choudhary (A)

Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. jeffkarp@mit.edu achoudhary@bwh.harvard.edu.
Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Divisions of Renal Medicine and Engineering, Brigham and Women's Hospital, Boston, MA 02115, USA.
Chemical Biology Program, Harvard University, Cambridge, MA 02138, USA.

Jeffrey M Karp (JM)

Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. jeffkarp@mit.edu achoudhary@bwh.harvard.edu.
Center for Nanomedicine, Harvard Stem Cell Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.
Proteomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH